GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation
Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
To test whether GnRHa withheld 2-3 days before ovulation trigger reduces the incidence of
ovarian hyperstimulation syndrome (OHSS) in infertile high-risk patients with polycystic
ovaries (PCOs) who have been treated with gonadotropins for in vitro fertilization (IVF) or
Intracytoplasmic sperm injection (ICSI).